Ruti Aga banned for six years: a fake prescription from a family member and the price of a cover-up

Da Nang was raining from four in the morning. I still went out to Nguyen Tat Thanh Road, because the habit has become a schedule: twelve kilometres before the sky is fully light. There is a stretch on that coastal road I love most, from the eighth kilometre onward, where the streetlights thin out and only the spill from late-night seafood restaurants and the sound of waves against the stone embankment remain. Running through it, I always remember a line I wrote years ago, back when I was drifting between two sporting worlds: in the places the light does not reach, there are dreams still in training.

That morning I came home, made coffee, opened my phone. And read a line that dissolved the warmth of the run: Ruti Aga, the Ethiopian marathon runner, banned for six years.

I know Aga. Not in the intimate sense, but in the way that anyone who has followed athletics for more than a decade knows a face, a stride, the way a runner holds rhythm at the thirtieth kilometre. In 2026 she won the Tokyo Marathon. She has finished runner-up three times at races in the World Marathon Majors system, the most prestigious tier of long-distance road racing. In women's marathon, that is the top floor, the floor where people stop asking who won and start asking who is still fit enough to stand on the start line.

Then that name appeared in a statement from the Athletics Integrity Unit, the independent integrity body of World Athletics. The content: a positive test for methylprednisolone at a half marathon in China in March, plus a heavier charge, the falsification of evidence during results management.

The detail that left me sitting still in the kitchen longer than necessary: the prescription Aga used in her defence was issued by a clinic that does not exist. The signature belonged to a family member with no medical registration. That person claimed to have used an old prescription pad from a former workplace, and the former workplace confirmed to the AIU that the person had never worked there.

From the virtual stand, I heard my heart beat in time with the contest, but this time the beat was something else. Not the rhythm of a finishing sprint. The rhythm of someone reading a file in which every link fits together too perfectly, and all of it against one athlete.

CONTEXT: A THIRTY-TWO-YEAR-OLD WOMAN AND ONE PIECE OF PAPER

Aga is 32. For a female marathoner, that is the extended peak, not the decline. Over 42.195 kilometres, women commonly hold elite form well past 35, because marathon is a discipline where the experience of pacing is worth as much as the physical base. A 32-year-old who has won Tokyo and finished runner-up at three Majors is at precisely the best point of her career.

In March she travelled to China for a half marathon and won it. I do not have the time from that race, and I will not guess. But I know the ecosystem that race belongs to: hundreds of mid-sized road races across China invite East African athletes to run for appearance fees, and that is real, steady income, important to Ethiopian and Kenyan runners in the second tier of world marathon running. Races like that are not championships. They are work.

After that race, Aga's sample returned an adverse finding for methylprednisolone. She offered an explanation: she was being treated for a knee injury.

The AIU opened its case. The final outcome was a six-year ban, effective from 10 September. The result of the Chinese half marathon is almost certainly annulled, along with its prize money.

The architecture of the sanction is the part worth reading closely, because it explains the whole story. Two years for the presence of a prohibited substance. Four years for tampering. Added together, six years, and under the WADA Code, when an athlete commits multiple anti-doping rule violations, the periods are served consecutively rather than concurrently. This is the point most readers of the news skip, and it is the point that makes the sanction as heavy as it is.

Put differently: the cover-up was punished at twice the rate of the underlying offence.

I have followed enough doping cases across both athletics and esports to know one thing: when an athlete receives far more than the minimum, the cause almost always lies in the paperwork, not in the sample.

CORE ANALYSIS: WHAT SUBSTANCE, WHAT SANCTION, AND WHY SIX YEARS

First, a technical correction that international media handled carelessly. Many reports called methylprednisolone a steroid. It is not an anabolic steroid. Methylprednisolone is a synthetic glucocorticoid, a corticosteroid, sitting in WADA class S9, and that class is prohibited in competition only. It is also a Specified Substance, a category the regulators acknowledge can plausibly enter the body inadvertently or for genuine therapeutic reasons.

That distinction is not academic trivia. It determines how the entire case should be read.

For a Specified Substance, the baseline sanction is two years, and the athlete has the right to show the substance was not taken for performance enhancement in order to reduce it. In other words, the substance side of this case was inherently the softer side. An athlete who tests positive for a corticosteroid after a knee injection, with complete medical records and a properly processed therapeutic use exemption, can walk away from the matter without a suspension, or with a far lighter one.

I say suspension in the esports sense because that is where I come from, but the analogy holds well. In League of Legends there are fights you win and games you lose because the map had no vision. You cannot control what you cannot see. In real sport, medical paperwork is that vision. An athlete can train right, eat right, sleep right, and still lose a career to the dark zone in their own file.

Now to the part that produced six years.

The AIU did not merely ask whether Aga had a prescription. They checked it. The clinic named on the document was contacted directly and confirmed the prescription was not theirs. Regulators checked the signing practitioner's registration and found no medical licence, and found that the signatory was a family member of the athlete. That person stated they had used an old prescription pad from a previous workplace, and the workplace denied ever employing them.

This is a closed evidentiary chain of the kind any defence lawyer would dread. No link requires inference. There is no room to argue that investigators misunderstood.

The lesson sits here: what moved the sanction from two years to six was not the substance, it was the paper. And that paper did not write itself.

I think a great deal about who sat with Aga to construct that story. An elite marathoner, a woman who can cover 42 kilometres at a pace I could not dream of holding for five, went to a relative to write a prescription. That is not the behaviour of an organised professional cheat. That is the behaviour of a frightened person with nobody advising her, who believed one sheet of paper was enough to seal a hole.

And this is where the case hurts far more than the way it is being told.

Across the East African road-running pipeline, many athletes have no personal lawyer, no anti-doping adviser, nobody to explain that a mechanism called a TUE exists, that if you need a corticosteroid injection for a swollen knee and you declare it in advance, you can be authorised. They have coaches, agents, a training group in Iten or Bekoji. They do not have a legal department.

Had Aga been properly advised from the day the sample came back, the script could have been entirely different: an honest declaration of knee treatment, real medical records, a retroactive TUE review, and a light or absent sanction. Instead, someone in her circle chose to invent a phantom clinic and a fake doctor. And the AIU exposed it with a few phone calls.

Here is the point I want to press: the modern anti-doping system is no longer weak at detecting forged documents. It has become very good at that. What remains weak is the supply of a lawful pathway to athletes before they fall into panic.

At 32, a six-year ban means Aga can return only at 38. Biologically, a female marathoner can still race at 38. But returning to World Marathon Majors podium level after six years without competition, without race scheduling, without regular testing, is close to something that does not happen. I have watched athletes come back after two years and struggle. Six years is a lifetime inside an athlete's cycle.

This is not a suspended sentence. It is a career-ending sentence, written in one short paragraph with no room for goodwill.

As for the landscape of women's marathon, Aga's absence leaves almost no dent. Ethiopia has a well so deep that losing one runner still leaves ten capable of running under 2:20. Kenya likewise. This is the point I need to state plainly, because it runs against public intuition: a high-profile doping case does not weaken a country with that kind of depth. It weakens exactly one person, and it scratches the brand that race organisers sell tickets with.

CONTRARIAN ANGLE: DO NOT TELL THIS STORY THE EASIEST WAY

There is a version of this story that is very easy to write, and very easy to share. That version tells of a poor Ethiopian girl, raised on dirt roads, running barefoot until an agent discovered her, until one day a knee swelled, a relative took pity and wrote her a prescription, and then the whole system turned around and swallowed her.

I understand the appeal of that version. I am someone who is always pulled toward the human story, toward the human face of every transfer and every sanction. But I have also learned something across years of writing: compassion does not need distortion to carry weight.

Every detail in the Aga case was a choice, not an accident. Choosing not to declare after an injection is a choice. Choosing a relative to sign a prescription is a choice. Choosing to state the document came from a clinic that exists is a choice. And that chain of choices was not produced by poverty. It was produced by the absence of anyone beside her saying this is wrong and this will be found out.

The second thing to say: do not turn this case into evidence for a larger story about systemic Ethiopian doping. I have seen that inference many times and it is always wrong in the same way. This is an individual case, executed with a clumsiness that borders on naivety, by people with no anti-doping expertise whatsoever. Organised doping does not leave traces like an old prescription pad and a clinic that does not exist. It is far cleaner, which is precisely why it is harder to catch.

The third, and this is where I want to linger longest: there is an inequality in this case that few name. An athlete from a country with a complete sports-medicine and sports-law system would never have landed here. She would have a team doctor, a TUE officer, a lawyer reading the AIU email before she read it. What she paid for was not only an injection of corticosteroid. She paid for having nobody there to do things correctly on her behalf.

I think about this in the language of esports, because that is the language I know. In a match, two teams share the same rules, the same map, the same champions. But the team with a coach reviewing the replay beats the team without one. The rules are not unfair. The preparation is. And in real sport, that preparation is distributed by geography and by income, so quietly that nobody calls it unfair.

The fourth: the way media name the substance is also distorting the story. When an outlet writes that an athlete was banned for steroids, the general reader pictures someone injecting testosterone to run faster. The reality is a glucocorticoid, a class prescribed to millions of people every day for joint inflammation. The two are very far apart morally and in severity. Conflating them makes the story easier to judge and leaves the reader misunderstanding the system handling it.

Finally, one detail I cannot leave out. Every finish line has an untold story. Here, the untold story is the story of paperwork. Nobody will make a film about it. Nobody will raise a statue. Yet that is exactly where the career of a Tokyo champion ended.

TAKEAWAY: WHAT DESERVES TO BE SAID AGAIN

I am not writing this to conclude that Aga is innocent. She had a prohibited substance in her body, and she produced a forged prescription. Both are established, and I have no reason to doubt a file with evidence this tight.

What I want to say is that we are reading this case along the wrong axis. We are reading it as a story about deceit, when it is more accurately a story about a deficit of support infrastructure. A world-class athlete, a woman who can run 42 kilometres faster than almost the entire human population, did not have a single person who knew how to complete a medical form properly.

If world athletics wants fewer cases like this, the most effective measure is not harsher penalties. The most effective measure is a free advice line, staffed by real people, at training hubs in East Africa, and paying someone who knows the rules. A twenty-minute phone call can save a ten-year career. The cost calculus is so simple it is hard to understand why it has not been done.

For Vietnam's fast-growing running community, with hundreds of mass-participation marathons appearing each year and more of us taking painkillers and anti-inflammatories before a race, the Aga case is not an Ethiopian story. It is a reminder that a prohibited list exists for competition days, that corticosteroids sit on it, and that how we handle a small mistake decides the size of the consequence.

The next morning I still went out along Nguyen Tat Thanh Road. Still twelve kilometres. At the stretch where the lights thin, I thought about a 32-year-old woman I have never met, who will never run Tokyo again.

The stadium is empty, but the echo of passion never runs dry. Only sometimes the echo does not come from the stands. It comes from a piece of paper that someone never learned to write correctly.